Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro
- PMID: 12568397
- DOI: 10.1359/jbmr.2003.18.2.204
Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro
Abstract
Nitrogen-containing bisphosphonates, such as alendronate and ibandronate, inhibit bone resorption by preventing protein prenylation in osteoclasts, whereas non-nitrogen-containing bisphosphonates, such as clodronate, are metabolized to nonhydrolyzable analogs of ATP, resulting in osteoclast apoptosis. Because these two classes of bisphosphonates have different molecular mechanisms of action, we examined in vitro whether combined treatment with clodronate and alendronate would alter antiresorptive effectiveness. Although, in cultures of rabbit osteoclasts, the antiresorptive effect of 10 microM alendronate was increased by the addition of clodronate, the effect of higher concentrations of alendronate was not altered by addition of clodronate. Furthermore, the inhibition of protein prenylation in osteoclasts caused by higher alendronate concentrations was partially prevented by cotreatment with clodronate. As in osteoclasts, the inhibition of protein prenylation in J774 cells caused by alendronate or ibandronate treatment was dose-dependently prevented by cotreatment with clodronate. Furthermore, alendronate-induced J774 apoptosis was significantly inhibited in the presence of clodronate. The presence of clodronate also decreased the short-term cellular uptake of [14C]ibandronate. These observations suggest that combined treatment with clodronate could enhance the antiresorptive effect of a low concentration of nitrogen-containing bisphosphonate, but clodronate can also antagonize some of the molecular actions and effects of higher concentrations of nitrogen-containing bisphosphonates. The exact molecular basis for the antagonistic effects between bisphosphonates remain to be determined, but could involve competition for cellular uptake by a membrane-bound transport protein.
Similar articles
-
Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.J Bone Miner Res. 1998 Apr;13(4):581-9. doi: 10.1359/jbmr.1998.13.4.581. J Bone Miner Res. 1998. PMID: 9556058
-
Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.J Bone Miner Res. 2000 Aug;15(8):1467-76. doi: 10.1359/jbmr.2000.15.8.1467. J Bone Miner Res. 2000. PMID: 10934645
-
The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.Arthritis Rheum. 2001 Sep;44(9):2201-10. doi: 10.1002/1529-0131(200109)44:9<2201::aid-art374>3.0.co;2-e. Arthritis Rheum. 2001. PMID: 11592386
-
Bisphosphonates: from the laboratory to the clinic and back again.Bone. 1999 Jul;25(1):97-106. doi: 10.1016/s8756-3282(99)00116-7. Bone. 1999. PMID: 10423031 Review.
-
New insights into the molecular mechanisms of action of bisphosphonates.Curr Pharm Des. 2003;9(32):2643-58. doi: 10.2174/1381612033453640. Curr Pharm Des. 2003. PMID: 14529538 Review.
Cited by
-
Bisphosphonate treatment in the oim mouse model alters bone modeling during growth.J Biomech. 2008 Dec 5;41(16):3371-6. doi: 10.1016/j.jbiomech.2008.09.028. Epub 2008 Nov 20. J Biomech. 2008. PMID: 19022450 Free PMC article.
-
Role of connexin 43 in the mechanism of action of alendronate: dissociation of anti-apoptotic and proliferative signaling pathways.Arch Biochem Biophys. 2012 Feb 15;518(2):95-102. doi: 10.1016/j.abb.2011.12.022. Epub 2012 Jan 3. Arch Biochem Biophys. 2012. PMID: 22230328 Free PMC article.
-
Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation.Curr Osteoporos Rep. 2022 Dec;20(6):505-515. doi: 10.1007/s11914-022-00756-5. Epub 2022 Oct 6. Curr Osteoporos Rep. 2022. PMID: 36201122 Free PMC article. Review.
-
Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.BMC Cancer. 2008 Mar 28;8:81. doi: 10.1186/1471-2407-8-81. BMC Cancer. 2008. PMID: 18371232 Free PMC article.
-
Macrophages as Potential Therapeutic Targets in Acute Myeloid Leukemia.Biomedicines. 2024 Oct 11;12(10):2306. doi: 10.3390/biomedicines12102306. Biomedicines. 2024. PMID: 39457618 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials